Click here to return to main plasmids page

 

 

 

 

 

 

 

Papillomaviruses

Paper Name

Reference

Lab Name

Distribute?

Resistance

Notes

BPV1

pSheLL

[1]

pXLº

AddGene.org

kan

Bicistronic, too large to self-package*

 

 

 

 

 

 

 

CRPV

pCRPVsheLL

[2]

p¢LLw

yes

amp

Bicistronic, too large to self-package*

 

 

 

 

 

 

 

HPV1

p1sheLL

unpublished

p1LLw

not yet

amp

HPV1 gives poor L1 yield and HPV1 pseudovirus is poorly infectious

 

 

 

 

 

 

 

HPV2

p2sheLL

unpublished

p2LLw

yes

amp

This plasmid produces good yields of HPV2 prototype L1/L2 particles that have essentially no detectable infectivity on any tested cell line.

 

pRaLw

[3] [4]

pRŠLw

 

 

This variant (EF362755) HPV2 L1 produces pseudoviruses with detectable (but still extremely poor) infectious titer. Harvest 72h post-transfection

 

paL2

[3]

º

 

 

HPV2 L2 expression plasmid

 

 

 

 

 

 

 

HPV5

p5sheLL

[5]

p5LLw

yes

amp

Bicistronic, too large to self-package*.  HPV5 has high particle to infectivity ratio on many cell types

 

 

 

 

 

 

 

HPV6

p6sheLLr  

[6]

p6LLw2

yes

amp

  orignal "p6sheLL" had an unexpected duplication in the backbone due to a cloning error.  The duplication was repaired in p6sheLLr.  p6sheLL and p6sheLLr give essentially identical titer yields for HPV6 pseudovirus production.

 

 

 

 

 

 

 

HPV11

p11L1w

[7]

p11Lw

yes, MŸller MTA

kan

Titer of HPV11 pseudovirus is very poor.  Requires MŸller MTA.

 

p11L2w

[8]

p11ºw

yes, MŸller MTA

kan

 

 

 

 

 

 

 

 

HPV16

p16sheLL

[5, 9]

p16LLw

yes, MŸller MTA

amp

Replaces pXuLL.  Bicistronic, too large to self-package*.  Requires MŸller MTA.

 

p16L1L2

[10, 11]

phŸLº, frankenvirus

yes, MŸller MTA

zeo

Synthetic HPV capable of self-packaging. Suitable for infectious amplification in 293TT cells.  This plasmid is prone to collapse*

 

 

 

 

 

 

 

HPV18

p18sheLL

[2, 12]

p18LLw

AddGene.org

amp

Bicistronic, too large to self-package*

 

 

 

 

 

 

 

HPV27

Senger et al

[3]

 

 

 

 

 

 

 

 

 

 

 

HPV31

p31sheLL

[2, 13]

p31LLw

yes, Kanda MTA

amp

Bicistronic, too large to self-package*.  Requires Kanda MTA.

 

 

 

 

 

 

 

HPV35

p35sheLL

[14]

5psh35F

yes, contact Simon Beddows

amp

HPV35 L1 and L2 genes codon optimised for mammalian expression. Requires HPA UK MTA

 

 

 

 

 

 

 

HPV38

Faust et al

[15]

 

Faust et al

 

 

 

 

 

 

 

 

 

HPV39

p39sheLL

[14]

39pshC

yes, contact Simon Beddows

amp

HPV35 L1 and L2 genes codon optimised for mammalian expression. Requires HPA UK MTA

 

 

 

 

 

 

 

HPV45

p45sheLL

[2, 5]

p45LLw

AddGene.org

amp

Bicistronic, too large to self-package*

 

 

 

 

 

 

 

HPV52

p52sheLL

[16]

p52LLw

yes

amp

Bicistronic, too large to self-package*.  Poor titer yield.  Requires Kanda MTA.

 

 

 

 

 

 

 

HPV57

Senger et al

[3]

 

Senger et al

 

 

 

 

 

 

 

 

 

HPV58

p58sheLL

[13]

p58LLw

yes, Kanda MTA

amp

Bicistronic, too large to self-package*.  Requires Kanda MTA.

 

 

 

 

 

 

 

HPV59

p59sheLL

[14]

59pshB

yes, contact Simon Beddows

amp

HPV35 L1 and L2 genes codon optimised for mammalian expression. Requires HPA UK MTA

 

 

 

 

 

 

 

MusPV1

pMusheLL

unpublished

pMuLLw

Ask

amp

Mammalian expression plasmid with codon modified L1 and L2 genes of Mus musculus papillomavirus type 1*

 

pMusPV

[17, 18], unpub.

pMusPV

Ask

zeo

Synthetic Mus musculus papillomavirus type 1 clone

 

 

 

 

 

 

 

Polyomaviruses

 

 

 

 

 

 

BKV-I

pCAG-BKV

[19]

 

Nakanishi et al

 

VP1/2/3 packaging plasmid for BKV serogroup I (isolate KOM5) reporter vectors

 

pBKV-Ia

Unpublished

pIaw

Yes

zeo

Codon modified BKV genotype Ia VP1 expression plasmid

 

 

 

 

 

 

 

BKV-IV

pwB

[20]

pwB

AddGene.org

zeo

VP1 based on BKV serogroup IV isolate A-66H [21]

 

pwB2b

[20]

pwB2b

AddGene.org

zeo

BKV-IV VP1/VP2 dual expression plasmid

 

pwB3b

[20]

pwB3b

AddGene.org

zeo

BKV-IV VP1/VP3 dual expression plasmid

 

ph2b

[20]

ph2b

AddGene.org

zeo

BKV-IV VP2 expression plasmid

 

ph3b

[20]

ph3b

AddGene.org

zeo

BKV-IV VP3 expression plasmid

BKV variants

various

MS in prep

Various

Yes

zeo

Codon modified VP1 ORFs from various BKV genotypes

 

 

 

 

 

 

 

HPyV6

pHPyV6-607a

[22]

pe1D

AddGene.org

zeo

Reference clone of human polyomavirus 6

 

p6VP1

[22]

pe1VP1

AddGene.org

zeo

Human polyomavirus 6 VP1 expression construct

 

 

 

 

 

 

 

HPyV7

pHPyV7-713a

[22]

pe2S

AddGene.org

zeo

Reference clone of human polyomavirus 7

 

p7VP1

[22]

pe2VP1

AddGene.org

zeo

Human polyomavirus 7 VP1 expression construct

 

 

 

 

 

 

 

HPyV10

p10ww

[23, 24]

p10ww

yes

zeo

Reference clone of human polyomavirus 10 (MWPyV)

 

 

 

 

 

 

 

MCV

pMCV-R17a

[22]

pMCV-L

AddGene.org

kan

Reference clone of wild-type MCV from healthy skin

 

pMCV-R17b

[22]

p17A

yes

zeo

wt MCV clone. Seems to replicate a bit better than R71a [25]

 

pMCV-16b

unpublished

p16A

yes

zeo

MCV–R17a chimera with NCRR of Asian isolate MCV-16b

 

pwM

[26]

pwM

AddGene.org

zeo

Merkel cell polyomavirus (MCV) VP1 expression construct

 

ph2m

[26]

ph2m

AddGene.org

zeo

MCV VP2 expression construct

 

pwM2m

[27]

pwM2m

yes

zeo

MCV VP1/VP2 dual expression (VP2 expression relatively weak)

 

pMshell

unpublished

pMmw

yes

amp

MCV VP1/VP2 expression, too big to self-package*

 

 

 

 

 

 

 

MPyV

pwP

[26]

pwP

AddGene.org

zeo

Mouse polyomavirus (MPyV) VP1 expression construct

 

ph2p

[26]

ph2p

AddGene.org

zeo

MPyV VP2 expression construct

 

ph3p

[26]

ph3p

AddGene.org

zeo

MPyV VP3 expression construct

 

 

 

 

 

 

 

*Plasmids >10kb can be unstable in E. coli. 

 

 

 

 

Growing bacterial starter cultures at 30¼C and/or using Invitrogen STBL2 or Stratagene XL10-Gold bacteria may decrease the risk of plasmid collapse.

 

 

1.         Buck, C.B., et al., Efficient intracellular assembly of papillomaviral vectors. J Virol, 2004. 78(2): p. 751-7.

2.         Roberts, J.N., et al., Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med, 2007. 13(7): p. 857-61.

3.         Senger, T., et al., Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs. Vaccine, 2010. 28(6): p. 1583-93.

4.         Wang, W., et al., Detection of HPV-2 and identification of novel mutations by whole genome sequencing from biopsies of two patients with multiple cutaneous horns. J Clin Virol, 2007. 39(1): p. 34-42.

5.         Buck, C.B., et al., Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog, 2006. 2(7): p. e69.

6.         Pastrana, D.V., et al., Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology, 2005. 337(2): p. 365-72.

7.         Mossadegh, N., et al., Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology, 2004. 326(1): p. 57-66.

8.         Kieback, E. and M. Muller, Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein. Virology, 2006. 345(1): p. 199-208.

9.         Leder, C., et al., Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol, 2001. 75(19): p. 9201-9.

10.       Buck, C.B. and C.D. Thompson, Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol, 2007. Chapter 26: p. Unit 26.1.

11.       Buck, C.B., et al., Arrangement of L2 within the papillomavirus capsid. J Virol, 2008. 82(11): p. 5190-7.

12.       Pastrana, D.V., et al., Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology, 2004. 321(2): p. 205-16.

13.       Kondo, K., et al., Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology, 2007. 358(2): p. 266-72.

14.       Draper, E., et al., Neutralization of Non-Vaccine Human Papillomavirus Pseudoviruses from the A7 and A9 Species Groups by Bivalent HPV Vaccine Sera. Vaccine, 2011. 29: p. 8585-90.

15.       Faust, H., et al., Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin coated beads. J Gen Virol, 2010.

16.       Kondo, K., et al., Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes. J Med Virol, 2008. 80(5): p. 841-6.

17.       Joh, J., et al., Genomic analysis of the first laboratory-mouse papillomavirus. The Journal of general virology, 2011. 92(Pt 3): p. 692-8.

18.       Ingle, A., et al., Novel laboratory mouse papillomavirus (MusPV) infection. Vet Pathol, 2011. 48(2): p. 500-5.

19.       Nakanishi, A., et al., SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids. Virology, 2008. 379(1): p. 110-7.

20.       Schowalter, R.M., D.V. Pastrana, and C.B. Buck, Glycosaminoglycans and sialylated glycans sequentially facilitate merkel cell polyomavirus infectious entry. PLoS Pathog, 2011. 7(7): p. e1002161.

21.       Zhong, S., et al., Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol, 2009. 90(Pt 1): p. 144-52.

22.       Schowalter, R.M., et al., Merkel Cell Polyomavirus and Two Previously Unknown Polyomaviruses Are Chronically Shed From Human Skin. Cell Host Microbe, 2010. 7(6): p. 509-15.

23.       Buck, C.B., et al., Complete genome sequence of a tenth human polyomavirus. Journal of virology, 2012. 86(19): p. 10887.

24.       Siebrasse, E.A., et al., Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol, 2012. 86(19): p. 10321-6.

25.       Neumann, F., et al., Replication, Gene Expression and Particle Production by a Consensus Merkel Cell Polyomavirus (MCPyV) Genome. PLoS One, 2011. 6(12): p. e29112.

26.       Tolstov, Y.L., et al., Human Merkel cell polyomavirus infection II.  MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer, 2009. 125(6): p. 1250-6.

27.       Pastrana, D.V., et al., Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid. Virology, 2010. 405(1): p. 20-5.